AutoAnalyzer

From WikiMD's WELLNESSPEDIA

(Redirected from Dialyzer)

AutoAnalyzer is an automated analyzer using a flow technique called continuous flow analysis (CFA), first made by the Technicon Corporation. The instrument was invented in 1957 by Leonard Skeggs, PhD and commercialized by Jack Whitehead's Technicon Corporation. The first applications were for clinical analysis, but methods for industrial analysis soon followed. The AutoAnalyzer profoundly changed the field of Clinical chemistry and other medical testing.

History[edit]

The AutoAnalyzer was developed by Leonard Skeggs in the 1950s and was produced by the Technicon Corporation. The system helped to revolutionize clinical laboratory testing by allowing for faster, more accurate results. The AutoAnalyzer was the first instrument to automate the labor-intensive, manual chemical analysis process.

Design and Function[edit]

The AutoAnalyzer mixes samples and reagents in a continuous flow, allowing for high-speed, automated testing. The system uses a peristaltic pump to move fluids through the instrument's tubing, and a colorimeter to measure the color intensity of the sample, which indicates the amount of the substance present.

Applications[edit]

The AutoAnalyzer is used in a variety of fields, including Clinical chemistry, Pharmaceuticals, and Environmental testing. It can perform a wide range of tests, from routine clinical measurements such as glucose and urea to more complex tests for research purposes.

Advantages and Disadvantages[edit]

The AutoAnalyzer offers several advantages over manual testing, including speed, accuracy, and the ability to perform multiple tests simultaneously. However, it also has some disadvantages, such as the need for regular maintenance and the potential for errors if the instrument is not properly calibrated.

See Also[edit]

References[edit]


AutoAnalyzer[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.